ZTS - CIK 0001555280
Zoetis Inc. trades as ZTS and has a market capitalization of $34.08 B, making it the #424 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $9.47B, up 2.3% from the prior year and net income of $2.67B. This page tracks Zoetis Inc. through 2,040 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Zoetis Inc.'s revenue grew from $4.89B to $9.47B, a compound annual growth rate of 7.6%. Net profit margin expanded from 16.8% to 28.2% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-22 |
| Insider trade | 4 | 2026-05-21 |
| Major company event | 8-K | 2026-05-20 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
Zoetis to Participate in Upcoming Investor Conferences
Zoetis is the world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit **Zoetis.com**.
**Revenue of $2.3 Billion, Growing 3%, and Net Income of $601 Million, or $1.42 per Diluted Share, Flat and Increasing 6%, Respectively, on a Reported Basis**
Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results
The largest companies sharing Zoetis Inc.'s SEC industry classification (pharmaceutical preparations).
Zoetis Inc. (ZTS) has a market capitalization of $34.08 B as of 2026-06-10, ranking #424 among US-listed companies.
Zoetis Inc. reported revenue of $9.47B for fiscal year 2025, an increase of 2.3% year over year.
Yes. Zoetis Inc. reported net income of $2.67B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum